ChitogenX Inc. (CHGX.CN)
- Previous Close
0.0050 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0050 - 0.0050 - 52 Week Range
0.0050 - 0.0450 - Volume
0 - Avg. Volume
32,322 - Market Cap (intraday)
415,648 - Beta (5Y Monthly) -2.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
www.chitogenx.comRecent News: CHGX.CN
View MorePerformance Overview: CHGX.CN
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHGX.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHGX.CN
View MoreValuation Measures
Market Cap
415.65k
Enterprise Value
4.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-152.34%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.55M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
48k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-41k